<http://webisa.webdatacommons.org/prov/185874306>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/232580401> .
<http://webisa.webdatacommons.org/prov/317759416>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/232580401> .
<http://webisa.webdatacommons.org/232580401>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<prnewswire.com> .
<http://webisa.webdatacommons.org/232580401>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/232580401>	<http://www.w3.org/ns/prov#value>	"TNIB's products, technologies and patents are designed to harness the power of the immune system to improve the treatment of cancer and infections, such as HIV/AIDS and autoimmune diseases." .